Maryam Abrishamdar - Persian Gulf Physiology Research Center, Medical Basic Sciences Research Institute, Ahvaz Jundishpur University of Medical Sciences, Ahvaz, Iran
Alireza Sarkaki - Persian Gulf Physiology Research Center, Medical Basic Sciences Research Institute, Ahvaz Jundishpur University of Medical Sciences, Ahvaz, Iran
Yaghoob Farbood - Persian Gulf Physiology Research Center, Medical Basic Sciences Research Institute, Ahvaz Jundishpur University of Medical Sciences, Ahvaz, Iran

Objective(s): Parkinson’s disease (PD) is a neurodegenerative disorder involving the central nervous system associated with motor and non-motor impairments. Betulinic acid (BA) is a natural substance considered an antioxidative agent. This study aimed to investigate the therapeutic potential of BA on motor dysfunctions and globus pallidus (GP) local EEG power in a ۶-hydroxydopamine (۶-OHDA)-induced rat model of hemiparkinsonism.Materials and Methods: Adult Wistar rats were categorized into different groups, containing; Sham, PD, and treated groups including different doses of BA (۰.۵, ۵, and ۱۰ mg/kg, IP), and L-dopa (۲۰ mg/kg, PO, as positive control). The lesion was induced in the right medial forebrain bundle by injection of ۶-OHDA (۲۰ µg/kg). The treatment was begun just after the approved rotational test induced by apomorphine, ۱۴ days after ۶-OHDA administration. Motor behaviors such as catalepsy and stride-length and non-motor responses, including GP local EEG, were then assessed. Also, the levels of GSH, catalase, and concentration of dopamine in the brain tissue were measured. Results: Treatment of hemiparkinsonian rats with BA significantly improved catalepsy and stride-length (P<۰.۰۰۱ and P<۰.۰۱, respectively) and GP frequency bands’ powers (P<۰.۰۰۱). Moreover, the activities of GSH (P<۰.۰۰۱), catalase (P<۰.۰۰۱), and the concentration of dopamine (P<۰.۰۰۱) in the brain were increased.Conclusion: Current results proved the potent ability of BA to scavenge free radicals and to remove oxidative agents in the brain tissue. This natural product could be considered a possible therapeutic compound for motor and non-motor disorders in PD.

Betulinic acid, Catalase, Hemiparkinsonism, Local EEG, Stride-length